Status:
COMPLETED
PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?
Lead Sponsor:
University Ghent
Collaborating Sponsors:
Research Foundation Flanders
Special Research Fund, Belgium
Conditions:
High-grade Glioma of the Brain
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The aim of the study is to define preferential sites of tumour recurrence by observing tracer uptake in the tumour in sequential PET images with 18F-fluoromethylcholine (and perfusion MR, see also bel...
Eligibility Criteria
Inclusion
- 18 years or older
- patients with high-grade glioma who will undergo adjuvant radiochemotherapy after surgery
Exclusion
- low global performance state
- pregnancy
- lactation period
- presence of pacemaker, vascular clips in the brain ,epidural electrodes, implanted hearing device, set of false theeth attached by means of magnetes, wig attached by means of metal clips
Key Trial Info
Start Date :
January 12 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00628940
Start Date
January 12 2010
End Date
March 22 2018
Last Update
May 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000